TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+1.62%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.38B
AUM Growth
+$2.38B
(+1.4%)
Cap. Flow
+$234K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
40.59%
Holding
153
New
10
Increased
26
Reduced
19
Closed
10
Top Buys
| 1 |
Abbott
ABT
|
$37.5M |
| 2 |
Cencora
COR
|
$29.9M |
| 3 |
CVS Health
CVS
|
$21.4M |
| 4 |
Neurocrine Biosciences
NBIX
|
$20.7M |
| 5 |
Gilead Sciences
GILD
|
$15.1M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$34.4M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$24.8M |
| 3 |
Novo Nordisk
NVO
|
$16M |
| 4 |
Ventas
VTR
|
$15.8M |
| 5 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
$14.7M |
Sector Composition
| 1 | Healthcare | 88.83% |
| 2 | Real Estate | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
HCA Healthcare
HCA
$95.4B
| $25.8M | 1.05% |
334,998
| – | – |
|
|
MDCO
27
DELISTED
Medicines Co
MDCO
| $23.7M | 0.97% |
704,238
+139,800
| +25% | +$4.7M |
|
28
Humana
HUM
$37.5B
| $23.3M | 0.95% |
129,300
| – | – |
|
29
Jazz Pharmaceuticals
JAZZ
$7.99B
| $22.1M | 0.9% |
156,451
-22,640
| -13% | -$3.2M |
|
30
Agilent Technologies
A
$35.5B
| $22M | 0.9% |
495,450
-218,400
| -31% | -$9.69M |
|
|
31
CVS Health
CVS
$93B
| $21.4M | 0.87% |
+223,891
| New | +$21.4M |
|
32
GSK
GSK
$79.3B
| $18.8M | 0.77% |
434,200
+149,200
| +52% | +$6.47M |
|
33
Universal Health Services
UHS
$11.6B
| $18.1M | 0.74% |
134,680
| – | – |
|
34
AstraZeneca
AZN
$255B
| $17.3M | 0.71% |
574,000
+218,200
| +61% | +$6.59M |
|
35
SPDR S&P Biotech ETF
XBI
$5.29B
| $15.9M | 0.65% |
294,000
| – | – |
|
|
MDVN
36
DELISTED
MEDIVATION, INC.
MDVN
| $15.5M | 0.63% |
256,638
-410,662
| -62% | -$24.8M |
|
37
iShares Biotechnology ETF
IBB
$5.68B
| $14.8M | 0.61% |
57,670
| – | – |
|
38
Novartis
NVS
$248B
| $14M | 0.57% |
170,100
+77,400
| +83% | +$6.39M |
|
39
Omega Healthcare
OHI
$12.5B
| $14M | 0.57% |
413,116
| – | – |
|
40
Medical Properties Trust
MPW
$2.66B
| $14M | 0.57% |
920,393
-643,667
| -41% | -$9.79M |
|
|
DHC
41
Diversified Healthcare Trust
DHC
$903M
| $14M | 0.57% |
670,504
| – | – |
|
|
MNK
42
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $13.6M | 0.56% |
223,900
| – | – |
|
|
WELL.PRI
43
DELISTED
Welltower Inc.
WELL.PRI
| $13.6M | 0.55% |
200,000
| – | – |
|
44
Alnylam Pharmaceuticals
ALNY
$58.6B
| $13.5M | 0.55% |
243,995
+106,500
| +77% | +$5.91M |
|
45
Thermo Fisher Scientific
TMO
$183B
| $12.8M | 0.52% |
86,395
| – | – |
|
46
Sanofi
SNY
$122B
| $12.8M | 0.52% |
305,000
| – | – |
|
|
STJ
47
DELISTED
St Jude Medical
STJ
| $12.4M | 0.51% |
158,805
-97,005
| -38% | -$7.57M |
|
|
HZNP
48
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $12.4M | 0.5% |
749,900
| – | – |
|
49
Zimmer Biomet
ZBH
$20.8B
| $12.3M | 0.5% |
102,300
| – | – |
|
50
Idexx Laboratories
IDXX
$50.7B
| $12.3M | 0.5% |
132,352
| – | – |
|